We are monitoring the impact of COVID-19 on Europe Competent Cells Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 3352
Share on
Share on

Europe Competent Cells Market Research Report - Segmented By Type, By Application, By End User & By Country(UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2019-2024)

Pulished: August, 2019
ID: 3352
Pages: 125

Europe Competent Cells Market Size & Growth (2019 - 2024)

As per the research reports, the size of the Europe Competent Cells Market is valued at USD 0.24 billion in 2019 and estimated to grow at a CAGR of 9.5%, to reach USD 0.38 billion by 2024 during the forecast period 2019-2024.

The Europe Competent Cells market is developing at an exceptionally quick pace. Cells are made competent by a technique that uses calcium chloride and high-temperature shock. In genetics and molecular biology, competence is the ability of a cell to take up extracellular (isolated) DNA from its atmosphere in the procedure called transformation. E. coli cells are more likely to incorporate external DNA if their cell walls are transformed so that DNA can pass through more easily.

Expansions in biomolecular cloning study due to the arrival of new technologies and the growing commercial demand for molecular cloned products and recombinant proteins are some of the key factors driving the development of this market. However, rising market consolidation creating strong entry barriers and the huge cost of competent cell setup is limiting the growth of this market.

This research report segmented and sub-segmented into the following categories:

  • By Type: Chemically, Electrocompetent
  • By Application: Subcloning, Phage Display Library Production, Unstable DNA Cloning, High-Throughput Cloning, Mutagenesis
  • By End User: Pharmaceutical Companies, Academia 
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe

Cloning is estimated to command the major share of this market in 2017. Increasing study on cloning, driven by government funding is among the major reasons driving market growth in this segment. In 2016, the academic research institutes segment is likely to have for the largest share of the market.

Europe had low CAGR as compared to other regions except for MEA during the forecast period. The reasons for the same might be government policies.

Key players operating in the Europe Competent Cells Market profiled in this report are BioDynamics Laboratory, Inc. (Japan), GCC Biotech (India), SMOBIO Technology (Taiwan),  Thermo Fisher Scientific, Inc. (the U.S), QIAGEN N.V. (Germany), OriGene Technologies (U.S.), Merck KGaA (Germany), Promega Corporation (U.S.),  Bioline (U.K.), Zymo Research (U.S.), are the leaders in the Europe Competent Cells market.

1.Introduction           

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods   

                1.4 General Study Assumptions                

2. Research Methodology                    

                2.1 Introduction        

                2.2 Research Phases                      

         2.2.1 Secondary Research           

         2.2.2 Primary Research 

         2.2.3 Econometric Modelling      

         2.2.4 Expert Validation  

                2.3 Analysis Design  

                2.4 Study Timeline   

3. Overview                

                3.1 Executive Summary                

                3.2 Key Inferences  

                3.3 Epidemology       

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)             

                4.1 Market Drivers   

                4.2 Market Restraints                    

                4.3 Key Challenges  

                4.4 Current Opportunities in the Market       

5. Market Segmentation

                5.1 Type       

         5.1.1 Chemically               

         5.1.2 Electrocompetent

         5.1.3  Y-o-Y Growth Analysis, By Type    

         5.1.4  Market Attractiveness Analysis, By Type  

         5.1.5  Market Share Analysis, ByType     

                5.2 Application                 

         5.2.1 Cloning     

  5.2.1.1  Subcloning & Routine Cloning

  5.2.1.2 Phage Display Library Construction

  5.2.1.3 Toxic/Unstable Dna Cloning

  5.2.1.4 High-Throughput Cloning

         5.2.2 Protein Expression              

         5.2.3 Other Applications               

  5.2.3.1 Mutagenesis

  5.2.3.2 Large Plasmid Transformation

  5.2.3.4 Single-Stranded Dna Production

  5.2.3.5 Lentiviral Vector Production

         5.2.7 Y-o-Y Growth Analysis, By Application         

         5.2.8  Market Attractiveness Analysis, By Application      

         5.2.9  Market Share Analysis, By Application       

                5.3 End User                      

         5.3.1 Pharmaceutical Companies              

         5.3.2 Academia

         5.3.3 Y-o-Y Growth Analysis, By EndUser              

         5.3.4  Market Attractiveness Analysis, By EndUser           

         5.3.5  Market Share Analysis, By EndUser             

6. Geographical Analysis

                6.1 Introduction        

         6.1.1 Regional Trends    

         6.1.2 Impact Analysis     

         6.1.3 Y-o-Y Growth Analysis        

  6.1.3.1 By Geographical Area

  6.1.3.2 By Type

  6.1.3.3 By Application

  6.1.3.4 By EndUser

         6.1.4  Market Attractiveness Analysis     

  6.1.4.1 By Geographical Area

  6.1.4.2 By Type

  6.1.4.3 By Application

  6.1.4.4 By EndUser

         6.1.5  Market Share Analysis      

  6.1.5.1 By Geographical Area

  6.1.5.2 By Type

  6.1.5.3 By Application

  6.1.5.4 By EndUser

                6.2 U.K                 

                6.3 Spain      

                6.4 Germany                     

                6.5 Italy        

                6.6 France   

7.Strategic Analysis                 

                7.1 PESTLE analysis  

         7.1.1 Political     

         7.1.2 Economic 

         7.1.3 Social         

         7.1.4 Technological         

         7.1.5 Legal          

         7.1.6 Environmental       

                7.2 Porter’s Five analysis       

         7.2.1 Bargaining Power of Suppliers        

         7.2.2 Bargaining Power of Consumers    

         7.2.3 Threat of New Entrants     

         7.2.4 Threat of Substitute Products and Services              

         7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                  

                8.1 BioDynamics Laboratory, Inc. (Japan)       

         8.1.1 Overview 

         8.1.2 Product Analysis   

         8.1.3 Financial analysis  

         8.1.4 Recent Developments       

         8.1.5 SWOT analysis       

         8.1.6 Analyst View          

                8.2 GCC Biotech (India)                 

                8.3 SMOBIO Technology (Taiwan)     

                8.4 Thermo Fisher Scientific, Inc. (U.S)                   

                8.5 QIAGEN N.V. (Germany)                      

                8.6 OriGene Technologies (U.S.)       

                8.7 Merck KGaA (Germany)

                8.8 Promega Corporation (U.S.)                

                8.9 Bioline (U.K.)      

                8.10 Zymo Research (U.S.)   

9.Competitive Landscape                     

                9.1 Market share analysis     

                9.2 Merger and Acquisition Analysis

                9.3 Agreements, collaborations and Joint Ventures  

                9.4 New Product Launches  

10.Market Outlook and Investment Opportunities                   

Appendix                    

                a) List of Tables                

                b) List of Figures       

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Competent cells Market By Type, From 2019-2024 ( USD Million )
  2. Europe Chemically Market By Region, From 2019-2024 ( USD Million )
  3. Europe Electro Competent Market By Region, From 2019-2024 ( USD Million )
  4. Europe Competent cells Market By Application, From 2019-2024 ( USD Million )
  5. Europe SubCloning Market By Region, From 2019-2024 ( USD Million )
  6. Europe Phage Display Library Production Market By Region, From 2019-2024 ( USD Million )
  7. Europe Unstable DNA Cloning Market By Region, From 2019-2024 ( USD Million )
  8. Europe High-Throughput Cloning Market By Region, From 2019-2024 ( USD Million )
  9. Europe  Mutagenesis Market By Region, From 2019-2024 ( USD Million )
  10. Europe Competent cells Market By End User, From 2019-2024 ( USD Million )
  11. Europe Pharmaceutical Companies Market By Region, From 2019-2024 ( USD Million )
  12. Europe Academia Market By Region, From 2019-2024 ( USD Million )
  13. U.K. Competent cells Market By Type, From 2019-2024 ( USD Million )
  14. U.K. Competent cells Market By Application, From 2019-2024 ( USD Million )
  15. U.K. Competent cells Market By End User, From 2019-2024 ( USD Million )
  16. Germany Competent cells Market By Type, From 2019-2024 ( USD Million )
  17. Germany Competent cells Market By Application, From 2019-2024 ( USD Million )
  18. Germany Competent cells Market By End User, From 2019-2024 ( USD Million )
  19. France Competent cells Market By Type, From 2019-2024 ( USD Million )
  20. France Competent cells Market By Application, From 2019-2024 ( USD Million )
  21. France Competent cells Market By End User, From 2019-2024 ( USD Million )
  22. Italy Competent cells Market By Type, From 2019-2024 ( USD Million )
  23. Italy Competent cells Market By Application, From 2019-2024 ( USD Million )
  24. Italy Competent cells Market By End User, From 2019-2024 ( USD Million )
  25. Spain Competent cells Market By Type, From 2019-2024 ( USD Million )
  26. Spain Competent cells Market By Application, From 2019-2024 ( USD Million )
  27. Spain Competent cells Market By End User, From 2019-2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample